Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Gabapentin NDC 42385-980 by Laurus Labs Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
fig-1 - gabapentin fig 1
gabapentin-fig-10 - gabapentin fig 10
This text provides information about Gabapentin tablets, USP manufactured by Laurus Labs Limited. The tablets are available in 800 mg strength and are labeled with the NDC number 42385-980-17. The text also includes details about the lot numbers for the product.*
gabapentin-fig-11 - gabapentin fig 11
This text contains information about Gabapentin Tablets, USP in 800 mg dosage. It includes details on dispensing a Medication Guide to patients, dosing instructions, and storage conditions. The tablets are unit-dose and packaged as 100 tablets (10 x 10). The manufacturer is Laurus Generics Inc., located in Berkeley Heights, NJ, and the tablets are manufactured by Laurus Labs Limited in India. The text references a package insert for full prescribing information.*
fig-2 - gabapentin fig 2
fig-3 - gabapentin fig 3
This text provides information on the proportion of responders in patients with >50% reduction in pain score at the endpoint of controlled studies on PHN (Postherpetic Neuralgia). The data compares two studies and includes different dosage levels (GBP 3600, GBP 1800, GBP 2400). The significance of the results is indicated by the p-values provided for each study.*
fig-4 - gabapentin fig 4
This figure displays the Responder Rate in patients receiving Gabapentin compared to Placebo by Dose and Study. The information includes the results of Adjunctive Therapy Studies in Patients over 12 years old with Partial Seizures. The chart shows the relationship between the daily dose of Gabapentin (600 mg, 900 mg, 1200 mg, 1800 mg) and the Responder Rate.*
fig-5 - gabapentin fig 5
This text describes symptoms commonly associated with viral infections. These symptoms include lack of coordination, difficulty with speaking, tremor, swelling in legs and feet, feeling tired, fever, feeling drowsy, nausea and vomiting, jerky movements, double vision, difficulty with coordination, and unusual eye movement. These symptoms may point towards a need for medical attention and possible treatment.*
figure6 - gabapentin fig 6
This product is a tablet containing 600 mg of gabapentin USP. It is recommended to consult the package insert for complete prescribing information. The tablets should be stored in a tight, child-resistant container at a temperature between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C to 30°C (59°F to 86°F). Each bottle contains 30 tablets and comes with a medication guide for patients. The product is manufactured by Laurus Generics Inc. in New Jersey, USA, and by Laurus Labs Limited in India. The NDC code is 42385-979-30.*
gabapentin-fig-7 - gabapentin fig 7
gabapentin-fig-8 - gabapentin fig 8
gabapentin-fig-9 - gabapentin fig 9
Description: Each tablet of gabapentin USP contains 800 mg of the active ingredient. The medication should be stored at 20°C to 25°C. The packaging includes a medication guide for the patient. This prescription medication is dispensed in child-resistant containers to ensure safety. For full prescribing information, refer to the package insert. The tablets are available in a pack of 30 and are for prescription use only (Rx only). The manufacturing company is Laurus Generics Inc., located in Berkeley Heights, NJ, and manufactured by Laurus Labs Limited in India.*
Gabapentin-Structure - gabapentin structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.